In recognition of Rare Disease Day, Dr Kamran Iqbal, head of medical affairs and patient advocacy in global rare diseases at Chiesi UK, discussed with pharmaphorum the company’s evolving ro
As the demands of modern healthcare grow, new therapies are introduced at record speeds, and guidelines are quickly updated, it is key that medical education evolves to keep up.
Artificial intelligence (AI) is reshaping the pharmaceutical industry, driving advances from drug discovery and clinical trial acceleration to manufacturing optimisation and commercialisati
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
